The Valley Desk

NCT04203316 · Interventional trial

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

Overall registry status Active not recruiting

Phase 2

Conditions Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov